Combination cancer therapy with antiPSMA antibodies

Details for Australian Patent Application No. 2006204913 (hide)

Owner Cytogen Corporation

Inventors Becker, Michael; Goeckeler, William

Agent Allens Arthur Robinson

Pub. Number AU-A-2006204913

PCT Pub. Number WO2006/076525

Priority 60/643,589 14.01.05 US

Filing date 17 January 2006

Wipo publication date 20 July 2006

International Classifications

A61K 51/00 (2006.01) Preparations containing radioactive substances for use in therapy or testing

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

2 August 2007 PCT application entered the National Phase

  PCT publication WO2006/076525 Priority application(s): WO2006/076525

14 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006204914-Gravel pack shut tube with control line retention and method for retaining control

2006204911-Modified beta thymosin peptides